Oncology Institute, Inc. (TOI) Profit After Tax (2020 - 2026)

Oncology Institute (TOI) has 7 years of Profit After Tax data on file, last reported at -$2.1 million in Q1 2026.

• Quarterly Profit After Tax rose 86.97% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.6 million (up 29.29% YoY) and the FY2025 annual result came in at -$60.6 million, up 6.27% from the prior year.
• Profit After Tax rose to -$2.1 million in Q1 2026, from -$16.7 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $19.3 million in Q1 2022 to a low of -$30.0 million in Q1 2023.
• A 5-year average of -$14.1 million and a median of -$16.7 million in 2025 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2022 — Profit After Tax soared 2036.35% — and 2023, when it slumped 551.42%.
• Tracing TOI's Profit After Tax over 5 years: stood at -$28.1 million in 2022, then jumped by 33.35% to -$18.8 million in 2023, then declined by 19.89% to -$22.5 million in 2024, then advanced by 25.6% to -$16.7 million in 2025, then jumped by 87.48% to -$2.1 million in 2026.
• The last three Profit After Tax figures came in at -$2.1 million (Q1 2026), -$16.7 million (Q4 2025), and -$13.8 million (Q3 2025), per Business Quant data.